Psilocybin
Clinical Use of Ayahuasca in Brazil
This study explores the articulations between the ritual use of ayahuasca by Indigenous and religious communities, the scientific interest in its therapeutic…
Ritual use of hallucinogens and psychedelic medicine: Articulations around the clinical use of ayahuasca in Brazil
Author: Genís Oña Journal: Quaderns de l’Institut Català d’Antropologia Year: 2023About the study
This study explores the articulations between the ritual use of ayahuasca by Indigenous and religious communities, the scientific interest in its therapeutic effects and the hegemonic psychotherapeutic models built around hallucinogens.Abstract
There is currently a renewed academic interest in hallucinogenic drugs such as psilocybin or ayahuasca. The clinical use of hallucinogens has been accompanied by psychotherapeutic models that address their subjective effects. The clinical approach developed in Brazil is particularly interesting, since it does not have psychotherapeutic orientations or techniques of directionality of the subjective experience. This text discusses the complex crossroads that crystallize in Brazil and that occur between the use of ayahuasca in clinical settings, its use by Indigenous communities and religions, the relationships between these communities and the general Brazilian population, and the hegemonic therapeutic models built around hallucinogens. Link to the study Contact ICEERS Research team Photo by Guto de Lima on Flickr. The post Clinical Use of Ayahuasca in Brazil appeared first on ICEERS. ayahuasca psilocybin psychedelic hallucinogenic regulation research-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Law & Regulation1 week ago
Tryp Therapeutics, Exopharm merger approved by shareholders
-
LSD1 week ago
The First Wave of Blotter Acid Inspired Trippy Psychedelic Art
-
Law & Regulation1 week ago
Adastra reports record sales in 2023, but remains in the red
-
Psychedelics1 week ago
MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
-
Psilocybin6 days ago
Psychedelic Underground Celebrated in San Francisco on Bicycle Day Weekend